Aadesh Kumar

Aadesh Kumar

Auto-generated profile, based on publicly available information

Aadesh Kumar

Faculty of Pharmacy, Swami Vivekanand Subharti University, Meerut, U.P. 250005, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in INDIAN DRUGS
Verified
Journal Article
Closed access
AKAadesh Kumar
Aadesh Kumar
MRMahendra Rana
Mahendra Rana
MBMadan Bisht
Madan Bisht
ARAmita Joshi Rana
Amita Joshi Rana
Peristrophe bicalyculata posses expectorant, analgesic, anti-inflamatory, antipyretic and antibacterial properties and has been traditionally used for the management of pain, sprain, and bone fracture. In this study we have tried to incorporate bioactive components of P. bicalyculata in transdermal patches which were developed by solvent casting method. Formulated patches were further evaluated for thickness, folding endurance, moisture content and moisture reuptake. Formulations showing good folding endurance were selected for estimation of the drug content and in-vitro drug release. The patches showing drug content more than 90% and drug release 85% were selected and fitted for Zero-order kinetics. This study will help in the development of transdermal patch for the treatment of bone fracture.

1 January 2025
Verified
Journal Article
Open access
PDF file
SSSuraj Suraj
Suraj Suraj
AKAadesh Kumar
Aadesh Kumar
SWSwati Wadhawan
Swati Wadhawan
MPManish Pathak
Manish Pathak
Silver nanoparticles are widely recognized for their potent antimicrobial properties. Conventional synthesis methods rely on toxic chemicals and high energy input, posing environmental and biomedical concerns. This study presents an eco-friendly, cost-effective synthesis of AgNPs using aqueous leaf extracts of Neem (Azadirachta indica) and Eucalyptus (Eucalyptus globulus) as reducing and stabilizing agents. Optimization of synthesis parameters, including extract-to-silver nitrate ratio, temperature, and incubation time, yielded stable, uniformly dispersed nanoparticles. Formation of AgNPs was confirmed visually and by UV–Vis spectroscopy (SPR peak 412–425 nm). TEM and SEM revealed spherical particles (Neem: 15–35 nm; Eucalyptus: 10–25 nm). XRD confirmed the crystalline face-centered cubic structure, while FTIR analysis indicated functional groups (hydroxyl, carbonyl, ether) involved in capping. Zeta potential analysis demonstrated greater colloidal stability for Eucalyptus-mediated AgNPs (−30.3 mV) compared to Neem (−22.1 mV). Antimicrobial assays against Gram-positive (Staphylococcus aureus, Bacillus subtilis), Gram-negative (Escherichia coli, Pseudomonas aeruginosa), and Candida albicans revealed significant activity of both Neem- and Eucalyptus-AgNPs, with Eucalyptus showing superior efficacy. One-way ANOVA and Tukey post-hoc analysis confirmed statistically significant differences (p < 0.001). This study demonstrates that green synthesis using plant extracts produces stable, biofunctional AgNPs with broad-spectrum antimicrobial activity, highlighting their potential for pharmaceutical applications such as wound dressings and topical antimicrobials.

20 October 2026 in Central Nervous System Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
TCTanu Chaudhary
Tanu Chaudhary
NDNidhi Dhama
Nidhi Dhama
SSShivangi Sangal
Shivangi Sangal
AKAadesh Kumar
Aadesh Kumar
MPManish Pathak
Manish Pathak
SHAH ALAM KHANSHAH ALAM KHAN
SHAH ALAM KHAN
Epilepsy continues to affect millions globally, and despite advances in treatment, many patients still struggle with drug-resistant forms of the disorder. Among the newer therapeutic options, racetam derivatives have garnered attention for their distinctive mechanism of action—modulating synaptic vesicle protein 2A (SV2A)—which distinguishes them from traditional antiepileptic drugs (AEDs). This review provides a closer examination of the structure–activity relationships (SAR) of racetam analogues, investigating how chemical modifications, such as aromatic substitution, halogenation, and alkyl chain extension, can significantly enhance key properties, including lipophilicity, blood–brain barrier penetration, metabolic stability, and receptor binding. By comparing well-known agents like piracetam and levetiracetam with newer, more refined molecules such as brivaracetam and seletracetam, we highlight the steady evolution in potency, selectivity, and pharmacokinetics. We also explore emerging strategies that aim to address current challenges in drug delivery and tolerability, ranging from stereochemical optimization to nanotechnology-based formulations and prodrug design. Recent findings from both preclinical and clinical studies (2021–2024) underscore the growing relevance of racetams in epilepsy care, highlighting the need for continued innovation in medicinal chemistry and translational research. Ultimately, racetam derivatives represent a compelling intersection of pharmaceutical design and neuropharmacology, offering a promising roadmap for the development of next-generation AEDs tailored to individual patient needs.


16 December 2021 in Asian Journal of Chemistry
Verified
Journal Article
Open access
NDNidhi Dhama
Nidhi Dhama
SUSucheta
Sucheta
AKAadesh Kumar
Aadesh Kumar
VVVikrant Verma
Vikrant Verma
SKSunil Kumar
Sunil Kumar
Piracetam is generally utilized as a nootropic drug, which is normally used in the treatment of CNS disorders. Piracetam is a cyclic compound and a derivative of γ-aminobutyric acid and improves learning, memory, brain metabolism, and ability. This drug belongs to the racetams group with the chemical name 2-oxo-1-pyrrolidine acetamide. The emphasis of this review article is to highlight different biological activities associated with piracetam and also some of its synthetic methodologies. Promising effects have been achieved in the management and treatment of several diseases for example alcoholism, Raynaud’s phenomenon, deep vein thrombosis and brain injury.

28 April 2023 in Asian Journal of Chemistry
Verified
Journal Article
Open access
NDNidhi Dhama
Nidhi Dhama
SUSucheta
Sucheta
AKAadesh Kumar
Aadesh Kumar
VVVikrant Verma
Vikrant Verma
RNRohan Narkhede
Rohan Narkhede
VPVaishali Patil
Vaishali Patil
Piracetam is a nootropic drug that has been used in clinical trials for decades, but is still a mystery due to a lack of understanding of its mechanism of action. In this research, sixteen novel piracetam derivatives were synthesized in three steps and characterized by IR, NMR and mass spectroscopic techniques. Based on the docking studies, two derivatives were identified as more active based on the drug receptor interactions studies and were further subjected to animal studies for the evaluation of the activity. Compounds 6 and 10 had shown a strong anticonvulsant activity based on the molecular docking studies. It was hypothesized from the synthesized analogues that the non-substitution with thio moiety at has a major effect on reducing the contagiousness of seizure discharge and increasing the seizure threshold.